Stock 7133 HYUGA PRIMARY CARE CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings HYUGA PRIMARY CARE Co.,Ltd.

Equities

7133

JP3794570006

Market Closed - Japan Exchange
Other stock markets
 07:00:00 15/05/2024 BST 		5-day change 1st Jan Change
1,665 JPY -4.31% Intraday chart for HYUGA PRIMARY CARE Co.,Ltd. -7.81% -11.95%
2023 HYUGA PRIMARY CARE Co.,Ltd. agreed to acquire MedicalMind Co., Ltd. from Hajime Urashima for ¥500 million. CI
2023 Tranche Update on HYUGA PRIMARY CARE Co.,Ltd.'s Equity Buyback Plan announced on September 15, 2023. CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The company's profit outlook over the next few years is a strong asset.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.

Weaknesses

  • The company appears highly valued given the size of its balance sheet.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
HYUGA PRIMARY CARE CO.,LTD. Stock HYUGA PRIMARY CARE Co.,Ltd.
-11.95% 78.97M -
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-30.70% 15.83B
B-
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-22.89% 12.31B
B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-24.53% 6.59B
B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+12.51% 6.45B
C
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-12.43% 5.94B
C+
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.15% 4.66B
D-
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+62.00% 4.59B
C
CLICKS GROUP LIMITED Stock Clicks Group Limited
-5.94% 3.96B
B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-8.76% 3.55B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 7133 Stock
  4. Ratings HYUGA PRIMARY CARE Co.,Ltd.